ArticleGenes2023

ERCC1 and MGMT Methylation as a Predictive Marker of Relapse and FOLFOX Response in Colorectal Cancer Patients from South Tunisia.

Dhouha Jamai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.